Arthur Winer
Principal Investigator · Inova Health Care Service
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Arthur Winer as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:53 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06789757 · The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)Inova Health Care Services · recruiting · Hepatocellular Carcinoma · principal investigator
- Ph2/Ph3NCT06007846 · A Prospective Study of Memantine in Patients With Cirrhosis and Liver CancerInova Health Care Services · recruiting · Hepatocellular Carcinoma, Cirrhosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:53 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed
- Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Biol Blood Marrow Transplant · 200541 citationsRCR 0.8
- Protection from scrotal hyperthermia in laptop computer users.Fertil Steril · 201114 citationsRCR 0.6
- First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer.Clin Colorectal Cancer · 20212 citationsRCR 0.1